Progenity raises $125M for prenatal genetics

San Diego biotech company Progenity said Tuesday it has raised $125 million in equity and debt.

Progenity said the money will help it develop products in the area of prenatal and women’s health genetics, and for gastrointestinal disease.

The privately held company said the financing was led by...